Infos AG

NOTE TO THE SHAREHOLDERS OF OSE IMMUNOTHERAPEUTICS

Paris (France), on June 20, 2025. Dear shareholders, We, Mrs. Dominique Costantini, Mr. Emile Loria and Mr. Alexis Peyroles, hereby inform the shareholders of OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the “Company”) of recent…

Read all

Infos AG

https://ose-ag2025.com/wp-content/uploads/2025/06/OSE-Pharma-Loria-Costantini-Peyroles-e1445893203257-1.jpg 1536 1024 OSE-AG25 OSE-AG25 https://ose-ag2025.com/wp-content/uploads/2025/06/OSE-Pharma-Loria-Costantini-Peyroles-e1445893203257-1.jpg 23 June 2025 23 June 2025